Mammary Stem Cell Isolation via Antibody Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are unable to effectively identify and purify mammary stem cells and other subpopulations from mammary cell preparations, as existing colony assays fail to discriminate between stem cells and other colony-forming cells, and previous enrichment strategies, such as Sca-1 enrichment, result in low purity.
Innovation Solution
Development of antibody compositions that specifically bind to CD24, CD49f, CD45, Ter 119, and CD31 to separate non-epithelial cells from epithelial cells, allowing for the enrichment of mammary stem cells, luminal-restricted colony-forming cells, and other subpopulations by flow cytometry, achieving high purity through a multi-step process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If colony assays are used to identify cells with growth potential, then all cells with growth potential can be detected, but the ability to discriminate between stem cells and other colony-forming cells is lost
Solution Approach 1:
The invention segments the population of colony-forming cells into distinct subsets based on their immunophenotypic characteristics. By using combinations of surface markers (such as Sca-1, CD24, CD49f, EpCAM), the method divides CFCs into stem cell-enriched populations and other CFC populations, allowing simultaneous detection of all growth-capable cells while discriminating between different cell types.
Solution Approach 2:
The invention introduces immunophenotypic markers as intermediary characteristics to bridge the gap between general colony-forming cell detection and specific stem cell identification. These surface markers serve as mediators that allow flow cytometry to distinguish stem cells from other CFCs based on their unique marker expression patterns, rather than relying solely on functional colony formation assays.
2Quantity of substance
If Sca-1 enrichment is used to identify mammary stem cells, then stem cells can be enriched, but the purity of the isolated population decreases
Solution Approach 1:
The invention further segments the Sca-1+ cell population by applying additional marker-based distinctions. By combining Sca-1 with other markers (CD24, CD49f, EpCAM), the method divides the enriched population into more homogeneous subsets, thereby increasing purity while maintaining stem cell enrichment.
Solution Approach 2:
The invention applies different marker expression thresholds and combinations to different cell populations. By defining specific phenotypic profiles (e.g., Sca-1+CD24lowCD49fhigh for stem cells versus other Sca-1+ populations), the method creates locally optimized enrichment strategies for different cell types within the broader Sca-1+ population, improving both purity and enrichment efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a purity of approximately 1 mammary stem cell per 20 sorted cells and effectively distinguishes stem cells from colony-forming cells, enabling the isolation of mammary cell subpopulations to a higher degree than previous methods, facilitating further study in breast cancer and cell biology.
Implementation Method 1
reacting the sample with an antibody composition capable of binding to antigens on non-epithelial cells under conditions so that conjugates are formed between the antibodies and the cells in the sample containing the non-epithelial antigens
Data Source
AI summary
The present invention relates to an improved method that permits the differential isolation of mouse mammary stem cells and colony forming cells (CFCs). The method involves depletion of non-epithelial cells from freshly dissociated mouse mammary tissue by incubation with an antibody composition containing antibodies specific for CD45, Ter119, CD35 and optionally CD140a. After formation of conjugates between the non-epithelial mammary cells and the antibodies specific for CD45, Ter119, CD35 and optionally CD140a, the cell conjugates are removed and the remaining epithelial cells are then incubated with an antibody composition containing antibodies specific for CD24 and CD49f. After formation of conjugates between the epithelial cells and the antibodies specific for CD24 and CD49f, the mouse mammary stem and the luminal-restricted CFC cells can be differentially isolated. The invention also relates to kits for carrying out this method and to the cell preparations prepared by this method.